SCHEMBL7705819

SCHEMBL7705819

FC(F)(F)c1c[c]c(-c2ccco2)c(C(F)(F)F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 5/20 0.38
PIK3R1 P27986 3/20 0.36
PIK3CA P42336 3/20 0.36
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 4/20 0.35
HPGD P15428 4/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TLR8 Q9NR97 2/20 0.35
AR P10275 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
JAK2 O60674 1/20 0.33
TP53 P04637 1/20 0.33
STAT3 P40763 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7705238 0.73 KIF11 (0.44) ALDH1A1KDM4ESMN1; SMN2RAB9ATSHR
SCHEMBL11287914 0.71 NOTUM (0.43) TSHRPOLB
SCHEMBL7707670 0.70 KCNJ11 (0.31)
SCHEMBL8104087 0.70 P2RX7 (0.36) ALDH1A1HPGDNPSR1ARTSHR
SCHEMBL7704880 0.69 KDM4E (0.33) ALDH1A1KDM4EKMT2ASMN1; SMN2MAPT
SCHEMBL7704656 0.69 ERN1 (0.39) ALDH1A1KDM4ENPSR1MEN1KMT2A
SCHEMBL7705821 0.68 CFTR (0.39) CFTRPIK3R1PIK3CAALDH1A1KDM4E
SCHEMBL8995621 0.68 CES2 (0.31)
SCHEMBL7702031 0.68 AR (0.41) ALDH1A1HPGDARMAPTNPC1
SCHEMBL7701994 0.68 CYP11B1 (0.36) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242399-A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB S.A. (BE) 2002-09-25 EP disclosed
WO-2001046167-A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB, S.A. (BE) 2001-06-28 WO disclosed